期刊文献+

原发性醛固酮增多症的内分泌功能诊断 被引量:2

Endocrine functional diagnosis in primary aldosteronism
原文传递
导出
摘要 原发性醛固酮增多症(原醛症)是继发性高血压最常见的原因之一,以低肾素和高醛固酮血症为特征,血浆醛固酮/肾素比值(ARR)是筛查原醛症的可靠指标。而口服高钠负荷试验、生理盐水试验、氟氯可的松抑制试验或卡托普利试验中的任何一项均可作为ARR阳性患者的确诊试验;肾上腺静脉插管采血(AVS)是原醛症分型诊断的金标准。 Primary aldosteronism is one of the most common causes of secondary hypertension, which is characterized by low plasma renin and high aldosterone, and a major reliable tool for screening primary aldosteronism is the plasma aldosterone/renin activity ratio (ARR). Any of the four confirmatory tests such as oral sodium loading, intravenous saline infusion, captopril challenge and fludrocortisone administration plus sodium loading may carry out in patients who have positive ARR. And adrenal vein sampling (AVS) is recommended as the golden standard to diagnose primary aldosteronism.
出处 《国际内分泌代谢杂志》 北大核心 2012年第6期393-395,共3页 International Journal of Endocrinology and Metabolism
关键词 原发性醛固酮增多症 诊断 肾素-血管紧张素-醛固酮 Primary aldosteronism Diagnosis Rennin-angiotensin-aldosterone
  • 相关文献

参考文献20

  • 1Young WF. Primary aldosteronism : renaissance of a syndrome. Clin Endocrinol (Oxf) ,2007,66 : 607-618.
  • 2Mathur A, Kemp CD, Durra U, et al. Consequences of adrenal ve- nous sampling in primary hyperaldosteronism and predictors of u- nilateral adrenal disease. J Am Coil Surg,2010,211: 384-390.
  • 3Mulatero P, Monticone S, Bertello C, et al. Evaluation of primary aldosteronism. Curr Opin Endocrinol Diabetes Obes, 2010, 17: 188-193.
  • 4Westerdahl C, Bergenfelz A, Isaksson A, et al. Primary aldostcron- ism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area. Scand J Prim Health Care,2011, 29 : 57-62.
  • 5Mulatero P, Monticone S, Bertello C, et al. Confirmatory tests in the diagnosis of primary aldosteronism. Horm Metab Res, 2010, 42:406-410.
  • 6Funder JW, Carey RM, Fardella C, et al. Case detection, diagno- sis, and treatment of patients with primary aldosteronism: an en- docrine society clinical practice guideline. J Clin Endocrinol Metab, 2008,93 : 3266 -3281.
  • 7Arlt W. A detour guide to the Endocrine Society Clinical Practice Guideline on case detection, diagnosis and treatment of patients with primary aldosteronism. Eur J Endocrinol,2010,162 :435-438.
  • 8Nishikawa T, Omura M, Satoh F, et al. Guidelines for the diagno- sis and treatment of primary aldosteronism-the Japan Endocrine Society 2009. Endocr J,2011,58:711-721.
  • 9Giacchetti G, Mulatero P, Mantero F, et al. Primary aldosteronism, a major form of low renin hypertension : from screening to diagno- sis. Trends Endocrinol Metab ,2008,19 : 104-108.
  • 10Solar M, Malirova E, Ballon M, et al. Confirmatory testing in pri- mary aldosteronism:extensive medication switching is not needed in all patients. Eur J Endocrinol,2012 ,166 :679-686.

二级参考文献22

  • 1Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab, 2004,89 : 1045-1050.
  • 2Loh KC, Koay ES, Khaw MC, et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab, 2000,85:2854-2859.
  • 3Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coil Cardiol, 2006,48:2293-2300.
  • 4Calhoun DA, Nishizaka MK, Zaman MA, et al. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension, 2002,40:892-896.
  • 5Umpierrez GE, Cantey P, Smiley D, et al. Primary aldosteronism in diabetic subjects with resistant hypertension. Diabetes Care, 2007,30 : 1699-1703.
  • 6Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol, 2005,45 : 1243-1248.
  • 7Rossi GP, Bernini G, Desideri G, et al. Renal damage in primary aldosteronism : results of the PAPY Study. Hypertension, 2006,48 : 232-238.
  • 8Pessina AC, Sacchetto A, Rossi GP. Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension. Adv Exp Med Biol, 1997,432:63-69.
  • 9Giacchetti G, Ronconi V, Lucarelli G, et al. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism : need for a standardized protocol. J Hypertens, 2006,24:737-745.
  • 10Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2008,93 : 3266-3281.

共引文献24

同被引文献15

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部